Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New York Prostate Institute (NYPI) is a specialized clinical center dedicated to the diagnosis and treatment of prostate cancer, with a world-renowned reputation for excellence in brachytherapy. As a high-volume center for permanent radioactive seed implantation, the institute has been instrumental in developing clinical protocols and tracking long-term outcomes for localized prostate disease. NYPI operates as a specialized division within the Northwell Health system, providing patients with access to advanced radiation oncology technologies including IMRT and IGRT. The institute's multidisciplinary approach combines expert clinical care with a focus on minimally invasive techniques to preserve patient quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York Prostate Institute.